Cytiva_Jan2022_mRNAVaccinesANewEra - 5

mRNA VACCINES: A NEW ERA OF BIOTHERAPEUTIC DEVELOPMENT
Changing the Status
Quo of Vaccine Production
Precision NanoSystems maintains that mRNA and
LNP technologies, microfluidics, and distributed
manufacturing will revamp vaccine production
The rapid onset and spread of SARS-CoV-2
resulting in the global COVID-19 pandemic
has had devastating effects on global health,
education, and economies. The long-term
fallout of this truly catastrophic event has
yet to be fully realized as many countries
are still battling rising infection rates, the
emergence of more infectious variants, vaccine
supply and distribution issues, and more.
COVID-19 has enhanced existing disparities
in wealth and resources where high-income
countries have over 200% population coverage
of vaccine doses, leaving developing countries
struggling to gain access to supply even with
efforts by the COVID-19 Vaccines Global Access
Facility (COVAX Facility) to facilitate equitable
global distribution.1 The focus on self-recovery
has overshadowed the need for global
GENengnews.com | 5
https://www.cytivalifesciences.com/en/us https://www.genengnews.com

Cytiva_Jan2022_mRNAVaccinesANewEra

Table of Contents for the Digital Edition of Cytiva_Jan2022_mRNAVaccinesANewEra

Contents
Cytiva_Jan2022_mRNAVaccinesANewEra - Cover1
Cytiva_Jan2022_mRNAVaccinesANewEra - Cover2
Cytiva_Jan2022_mRNAVaccinesANewEra - Contents
Cytiva_Jan2022_mRNAVaccinesANewEra - 4
Cytiva_Jan2022_mRNAVaccinesANewEra - 5
Cytiva_Jan2022_mRNAVaccinesANewEra - 6
Cytiva_Jan2022_mRNAVaccinesANewEra - 7
Cytiva_Jan2022_mRNAVaccinesANewEra - 8
Cytiva_Jan2022_mRNAVaccinesANewEra - 9
Cytiva_Jan2022_mRNAVaccinesANewEra - 10
Cytiva_Jan2022_mRNAVaccinesANewEra - 11
Cytiva_Jan2022_mRNAVaccinesANewEra - 12
Cytiva_Jan2022_mRNAVaccinesANewEra - 13
Cytiva_Jan2022_mRNAVaccinesANewEra - 14
Cytiva_Jan2022_mRNAVaccinesANewEra - 15
Cytiva_Jan2022_mRNAVaccinesANewEra - 16
Cytiva_Jan2022_mRNAVaccinesANewEra - 17
Cytiva_Jan2022_mRNAVaccinesANewEra - 18
Cytiva_Jan2022_mRNAVaccinesANewEra - 19
Cytiva_Jan2022_mRNAVaccinesANewEra - 20
Cytiva_Jan2022_mRNAVaccinesANewEra - 21
Cytiva_Jan2022_mRNAVaccinesANewEra - 22
Cytiva_Jan2022_mRNAVaccinesANewEra - 23
Cytiva_Jan2022_mRNAVaccinesANewEra - 24
Cytiva_Jan2022_mRNAVaccinesANewEra - 25
Cytiva_Jan2022_mRNAVaccinesANewEra - 26
Cytiva_Jan2022_mRNAVaccinesANewEra - 27
Cytiva_Jan2022_mRNAVaccinesANewEra - Cover3
Cytiva_Jan2022_mRNAVaccinesANewEra - Cover4
https://www.nxtbookmedia.com